U.S. Cities Skeptical Of FDA Warnings Against Medicine Imports From Canadian Firm

The Food and Drug Administration suggests consumers who get prescription drugs mailed to them via CanaRx are at risk of getting mislabeled or counterfeit drugs. But consumer watchdog groups say the FDA has supplied no evidence that

Critics question claims by federal officials that CanaRX jeopardizes patient safety. Many U.S. companies, cities, counties and school districts rely on the firm to help employees get cheaper medicine.

(Image credit: Hero Images/Getty Images)

Read the full post on Health Care : NPR

Phil Galewitz